Tomohiro Kameda

1PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 05, 2020
The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma.

Tomohiro Kameda, Tatsuya Takayama, Toru Sugihara

Pageof 1

Frequent Collaborators